| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment | Wang P.-H.; Pan S.-W.; CHIN-CHUNG SHU ; CHUNG-YU CHEN ; Wei Y.-F.; Cheng S.-L.; HAO-CHIEN WANG ; CHONG-JEN YU | Respiratory Medicine | 5 | 6 | |
| 2020 | Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease | CHIN-CHUNG SHU ; Wu M.-F.; Pan S.-W.; Wu T.-S.; HSIN-CHIH LAI ; Lin M.-C. | Journal of the Formosan Medical Association | 10 | 8 | |
| 2021 | Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease | Pan S.-W.; CHIN-CHUNG SHU ; Feng J.-Y.; JUNG-YIEN CHIEN ; JANN-YUAN WANG ; Chan Y.-J.; CHONG-JEN YU ; Su W.-J. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 5 | 4 | |
| 2017 | Microbiological persistence in patients with mycobacterium avium complex lung disease: The predictors and the impact on radiographic progression | Pan S.-W.; CHIN-CHUNG SHU ; Feng J.-Y.; JANN-YUAN WANG ; Chan Y.-J.; CHONG-JEN YU ; Su W.-J. | Clinical Infectious Diseases | 42 | 42 | |
| 2022 | PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis | Pan S.-W.; CHIN-CHUNG SHU ; Huang J.-R.; Lee C.-C.; Tseng Y.-H.; Hung J.-J.; Hsu P.-K.; Chen N.-J.; Su W.-J.; Feng J.-Y.; Chen Y.-M. | International Journal of Molecular Sciences | 3 | 3 | |
| 2022 | Prevalence of Latent Tuberculous Infection in Patients with Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country | Lee H.-S.; Wei Y.-F.; Tsai Y.-J.; Wang P.-H.; CHUNG-YU CHEN ; Pan S.-W.; CHIN-CHUNG SHU | Open Forum Infectious Diseases | 1 | 0 | |
| 2021 | Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization [El papel de la proteína 3 soluble con dominio de inmunoglobulina y mucina de células T para diferenciar la enfermedad pulmonar de colonización pulmonar por micobacterias no tuberculosas] | Pan S.-W.; CHIN-CHUNG SHU ; Lee C.-C.; Feng J.-Y.; Chan Y.-J.; Chen Y.-M.; Su W.-J. | Archivos de Bronconeumologia | 5 | 5 | |
| 2020 | Safety and treatment completion of latent tuberculosis infection treatment in the elderly population—A prospective observational study in Taiwan | Feng J.-Y.; Huang W.-C.; Lin S.-M.; Wang T.-Y.; Lee S.S.-J.; CHIN-CHUNG SHU ; Pan S.-W.; CHUNG-YU CHEN ; Lin C.-B.; Wei Y.-F.; Tung C.-L.; Li C.-P.; Su W.-J. | International Journal of Infectious Diseases | 12 | 11 | |
| 2020 | Treatment for Mycobacterium avium complex lung disease | Pan S.-W.; CHIN-CHUNG SHU ; Feng J.-Y.; Su W.-J. | Journal of the Formosan Medical Association | 10 | 11 | |
| 2021 | The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity | Wang P.-H.; Wu M.-F.; Hsu C.-Y.; Pan S.-W.; CHIN-CHUNG SHU ; Cheng S.-L. | Frontiers in Immunology | 3 | 3 |
